X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25) 25
humans (24) 24
oncology (17) 17
female (15) 15
male (13) 13
mesothelioma (13) 13
aged (12) 12
middle aged (12) 12
cancer (11) 11
malignant pleural mesothelioma (10) 10
mesothelioma - genetics (10) 10
mesothelioma - pathology (9) 9
expression (8) 8
asbestos (7) 7
aged, 80 and over (6) 6
animals (6) 6
mesothelioma - metabolism (6) 6
pleural neoplasms - genetics (6) 6
pleural neoplasms - pathology (6) 6
respiratory system (6) 6
adult (5) 5
lung neoplasms - genetics (5) 5
lung neoplasms - pathology (5) 5
mice (5) 5
asbestos - adverse effects (4) 4
case-control studies (4) 4
diagnosis (4) 4
diagnosis, differential (4) 4
dna (4) 4
exposure (4) 4
lung neoplasms - metabolism (4) 4
lung-cancer (4) 4
malignant mesothelioma (4) 4
melanoma (4) 4
risk factors (4) 4
tumors (4) 4
analysis (3) 3
asbestos exposure (3) 3
biomarkers, tumor - genetics (3) 3
cell biology (3) 3
cells (3) 3
deoxyribonucleic acid--dna (3) 3
development and progression (3) 3
dna repair (3) 3
effusions (3) 3
environmental exposure - adverse effects (3) 3
gene (3) 3
gene expression profiling (3) 3
genes (3) 3
genetic aspects (3) 3
genetic research (3) 3
genomes (3) 3
immunohistochemistry (3) 3
immunotherapy (3) 3
lines (3) 3
mesothelioma - diagnosis (3) 3
mesothelioma - drug therapy (3) 3
mesothelioma - etiology (3) 3
mesothelioma - virology (3) 3
multidisciplinary sciences (3) 3
occupational exposure - adverse effects (3) 3
pathology (3) 3
pleural mesothelioma (3) 3
pleural neoplasms - metabolism (3) 3
proliferation (3) 3
sensitivity and specificity (3) 3
simian virus 40 - physiology (3) 3
t-cells (3) 3
tumor cells, cultured (3) 3
tumor suppressor proteins - genetics (3) 3
ubiquitin thiolesterase - genetics (3) 3
xenograft model antitumor assays (3) 3
antibodies, monoclonal (2) 2
apoptosis (2) 2
apoptosis - drug effects (2) 2
asbestos - toxicity (2) 2
association (2) 2
biochemical research methods (2) 2
biological sciences (2) 2
biomarkers (2) 2
biomarkers, tumor - analysis (2) 2
biomarkers, tumor - blood (2) 2
biomarkers, tumor - metabolism (2) 2
biotechnology (2) 2
biotechnology & applied microbiology (2) 2
carcinogenesis (2) 2
carcinogens (2) 2
cell division - physiology (2) 2
cell line (2) 2
cell line, tumor (2) 2
cell lines (2) 2
cell proliferation - drug effects (2) 2
cell survival - drug effects (2) 2
cell-lines (2) 2
chemotherapy (2) 2
cohort studies (2) 2
differential-diagnosis (2) 2
disease models, animal (2) 2
dna repair - genetics (2) 2
dna repair genes (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Cancer, ISSN 0020-7136, 01/2017, Volume 140, Issue 1, pp. 197 - 207
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 3764 - 3764
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 02/2019, Volume 116, Issue 6, pp. 2226 - 2231
Malignant pleural mesothelioma (MPM) is an aggressive malignancy associated with exposure to asbestos, with poor prognosis and no effective therapies. The... 
Growth hormone-releasing hormone | Malignant pleural mesothelioma | GHRH antagonists | GHRH receptor | malignant pleural mesothelioma | APOPTOSIS | DIAGNOSIS | ACTIVATION | MULTIDISCIPLINARY SCIENCES | PROLIFERATION | LUNG-CANCER CELLS | P21 | PROMOTES SURVIVAL | UPDATE | growth hormone-releasing hormone | EXPRESSION | Lung Neoplasms - drug therapy | Mesothelioma - pathology | Apoptosis - drug effects | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Receptors, Neuropeptide - metabolism | Pleural Neoplasms - drug therapy | Pleural Neoplasms - metabolism | Receptors, Pituitary Hormone-Regulating Hormone - metabolism | Antineoplastic Agents - pharmacology | Receptors, Pituitary Hormone-Regulating Hormone - genetics | Pleural Neoplasms - pathology | Disease Models, Animal | Cell Survival - drug effects | Gene Expression | Receptors, Neuropeptide - genetics | Mitochondria - metabolism | Mitochondria - drug effects | Growth Hormone-Releasing Hormone - genetics | Mesothelioma - drug therapy | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Growth Hormone-Releasing Hormone - metabolism | Animals | Mesothelioma - metabolism | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Growth Hormone-Releasing Hormone - antagonists & inhibitors | Cell proliferation | Alternative splicing | Biotechnology | Reactive oxygen species | Asbestos | Matrix metalloproteinases | Lung cancer | Xenotransplantation | Mesothelioma | Antagonists | Malignancy | Cell adhesion & migration | Mitochondria | Rodents | Xenografts | Inhibition | Vascular endothelial growth factor | Growth factors | Cell survival | Insulin | Chemotherapy | Medical prognosis | Cell lines | Growth hormones | Growth hormone | Cell migration | Cancer | Apoptosis | Index Medicus | Biological Sciences
Journal Article
Cancer Letters, ISSN 0304-3835, 10/2017, Volume 405, pp. 38 - 45
Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer caused by asbestos exposure. An inherited predisposition has been suggested to explain... 
Homologous recombination repair | Mesothelioma | Germline mutation | DNA repair genes | Asbestos exposure | POPULATION | PANCREATIC-CANCER | SUSCEPTIBILITY | RISK | CROCIDOLITE ASBESTOS | PREVALENCE | BREAST-CANCER | MELANOMA | CARCINOGENESIS | ONCOLOGY | BAP1 MUTATIONS | Lung Neoplasms - genetics | Asbestos - toxicity | Genetic Predisposition to Disease | Pleural Neoplasms - genetics | Humans | Middle Aged | Risk Factors | Male | Mesothelioma - genetics | DNA Repair - genetics | Ubiquitin Thiolesterase - genetics | Pleural Neoplasms - etiology | Carcinogens - toxicity | Environmental Exposure - adverse effects | Lung Neoplasms - etiology | Tumor Suppressor Proteins - genetics | Aged, 80 and over | Germ-Line Mutation | Female | Aged | Environmental Pollutants - toxicity | Mesothelioma - etiology | Biotechnology | Asbestos | Gene mutations | DNA damage | Genes | DNA | Genetic research | Development and progression | Genetic aspects | Disease susceptibility | DNA repair | Asbestos industry | Genomics | Homologous recombination | Homology | Genomes | Family medical history | Carcinogenesis | Ovarian cancer | FANCC protein | Carcinogens | Repair | Deoxyribonucleic acid--DNA | BRCA2 protein | BRCA1 protein | Melanoma | Breast cancer | Exposure | Patients | Studies | Pancreatic cancer | Mutation | Health risk assessment | Cancer | Tumors | Index Medicus
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 03/2015, Volume 10, Issue 3, pp. 492 - 499
Journal Article
Genes, Chromosomes and Cancer, ISSN 1045-2257, 11/2018, Volume 57, Issue 11, pp. 573 - 583
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, pp. e61253 - e61253
Journal Article
Medical Oncology, ISSN 1357-0560, 6/2013, Volume 30, Issue 2, pp. 1 - 9
Journal Article
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 03/2019, Volume 14, Issue 3, pp. 527 - 539
Introduction: Malignant pleural mesothelioma (MPM) is an aggressive tumor strongly associated with asbestos exposure. Patients are usually diagnosed when... 
METASTASIS | Case-control discrimination | Asbestos exposure | Early biomarker | CANCER | ORGANIZATION | PROMOTES PROLIFERATION | INVASION | POLYMORPHISMS | ONCOLOGY | RESPIRATORY SYSTEM | EPIGENETIC AGE | Malignant pleural mesothelioma | DNA-methylation | PREDISPOSE | EXPRESSION | GERMLINE BAP1 MUTATIONS
Journal Article
International Journal of Cancer, ISSN 0020-7136, 2019
Malignant pleural mesothelioma (MPM) is a tumor with high chemoresistance and poor prognosis. MPM-initiating cells (ICs) are known to be drug resistant, but it... 
malignant pleural mesothelioma | chemoresistance | ABCB5 | initiating cells | Index Medicus
Journal Article
Lung Cancer, ISSN 0169-5002, 06/2018, Volume 120, p. 34
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.lungcan.2018.03.022... 
Ubiquitin | Antimitotic agents |